Data from the World Population Review for the U.S. and the World Health Organization for Europe reveal that America continues ...

Obesity extends far beyond carrying extra weight - it represents a chronic condition affecting millions globally. While ...

One participant lost 22% of her weight in nine months — substantially faster than the rate seen with approved GLP-1 drugs ...

More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.

Obesity is more than just a diet and exercise issue; it's deeply intertwined with psychological and social factors. Experts ...

A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy ...

Dr. Cheryl Kendall discusses urgent pediatric health concerns, offering solutions for childhood obesity and digital addiction ...

Eli Lilly wants to take big swings in Alzheimer's, ALS, chronic pain and other difficult diseases after its success in ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Shares of obesity-drug maker Novo Nordisk rose Friday after the Food and Drug Administration declared that the company’s popular medications Ozempic and Wegovy were no longer in shortage. A shortage o ...

In ongoing trials of Eli Lilly’s (LLY) next-generation obesity drug, several trial participants are losing too much weight, STAT’s Elaine Chen ...

Jan. 27, 2025 — A study shows that patients with obesity and fatty liver-related cirrhosis who had bariatric (weight-loss) surgery significantly lowered their future ... Signposting Children to ...